U.S. President Donald Trump speaks to the media before boarding Air Force One as he departs for Washington, D.C., at Morristown Municipal Airport in Morristown, New Jersey, U.S., May 25, 2025.
13:28 JST, May 26, 2025
MORRISTOWN, New Jersey, May 25 (Reuters) – U.S. President Donald Trump on Sunday expressed deep unhappiness at Russia’s weekend bombing of Ukraine, saying of Russian President Vladimir Putin, “I’m not happy with Putin.”
“I don’t know what’s wrong with him. What the hell happened to him? Right? He’s killing a lot of people. I’m not happy about that,” Trump told reporters at the airport in Morristown, New Jersey, as he prepared to return to Washington.
Trump spoke in reaction to a Russian barrage of 367 drones and missiles at Ukrainian cities overnight on Sunday, including the capital Kyiv, in the largest aerial attack of the war so far, killing at least 12 people and injuring dozens more.
Trump has been trying to get both sides to agree to a ceasefire in the three-year-old war in Ukraine and he spoke for more than two hours with Putin last week.
He raised the possibility of imposing more sanctions on Russia in response to the ongoing attacks.
“Always gotten along with him, but he’s sending rockets into cities and killing people, and I don’t like it at all,” Trump said.
Top Articles in News Services
-
Survey Shows False Election Info Perceived as True
-
Japan’s Nikkei Stock Average Falls as US-Iran Tensions Unsettle Investors (UPDATE 1)
-
Japan’s Nikkei Stock Average Touches 58,000 as Yen, Jgbs Rally on Election Fallout (UPDATE 1)
-
Japan’s Nikkei Stock Average Rises on Tech Rally and Takaichi’s Spending Hopes (UPDATE 1)
-
Japan to Ban Use of Power Banks on Airplanes
JN ACCESS RANKING
-
Producer Behind Pop Group XG Arrested for Cocaine Possession
-
Japan PM Takaichi’s Cabinet Resigns en Masse
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
Videos Plagiarized, Reposted with False Subtitles Claiming ‘Ryukyu Belongs to China’; Anti-China False Information Also Posted in Japan
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed

